Biloba Forte

Active material: Ginkgo Biloba
When ATH: N06DX02
CCF: Phyto, improves cerebral and peripheral circulation
ICD-10 codes (testimony): F07, F07.2, G93.4, H35.3, H36.0, H81, H93.0, I73.0, I73.1, I73.9, I79.2, R42, T90
When CSF: 01.14.08
Manufacturer: KRKA d.d. {Slovenia}

Pharmaceutical form, composition and packaging

◊Capsules Pink colour; contents of capsules – Powder from light to dark brown color with visible particles darker.

100 mg of extract contains 19.2 mg flavonovыh glycosides and ginkgo 4.8 mg terpene lactones (ginkgolides and bilobalide).

Excipients: lactose monohydrate, corn starch, talc, silicon oxide colloid, magnesium stearate.

The composition of the shell capsules: Titanium dioxide (E171), colorant sunset yellow (E110), carmine dye (Ponceau 4R) (E124), dye Brilliant Black (E151), patented blue dye (E131), metilparagidroksiʙenzoat, propilparagidroksibenzoat, gelatin.

10 PC. – blisters (2) – packs cardboard.
10 PC. – blisters (6) – packs cardboard.

Pharmacological action

Herbal medicines, improves cerebral and peripheral circulation. The active compounds of the extract of Ginkgo biloba (flavonoid glycosides, terpene lactones) help to strengthen and improve the elasticity of the vascular wall, improve the rheological properties of blood. Use of the drug leads to improved microcirculation, It increases the supply of the brain and peripheral tissues of oxygen and glucose. Normalizes metabolism in cells, prevents platelet aggregation, It inhibits platelet aggregation. Extends the small arteries, increases the tone of veins, It regulates the blood supply vessels.

Pharmacokinetics

The pharmacokinetic parameters of extract of ginkgo biloba are difficult to quantify because of the multi-component composition of the extract.

Testimony

- Encephalopathy of various etiologies (stroke, traumatic brain injury, old age), accompanied by a decrease in attention and / or memory, infringement of intellectual abilities, anxiety, fear, sleep disorders;

- Violation of the peripheral circulation and microcirculation (incl. arteriopathy of the lower limbs), Raynaud's syndrome;

- Neurosensory impairment (dizziness, noise in ears, gipoakuziя);

- Age-related macular degeneration;

- Diabeticheskaya retinopathy.

Dosage regimen

Assign 1 caps. 2 times / day (in the morning and in the evening). The duration of treatment should be at least 3 Months, improvement observed after 1 months of therapy. If necessary, may conduct re-treatment on doctor's advice.

The capsules should be swallowed whole, with a little water.

Side effect

Rarely: allergic reactions (skin rash, itch), dyspepsia, headache.

Contraindications

- Reduced blood clotting;

- Erosive gastritis;

- Gastric ulcer and duodenal ulcer in the acute phase;

- Acute cerebrovascular accident;

- Acute myocardial infarction;

- Childhood and adolescence up 18 years;

- Pregnancy;

- Lactation (breast-feeding);

- Hypersensitivity to the drug.

Pregnancy and lactation

Bilobil^® Forte is not recommended during pregnancy and lactation (breast-feeding).

Cautions

Do not exceed the recommended dose.

You can receive capsules with food and drink.

Overdose

Currently, cases of drug overdose biloba^® Forte has not been reported.

Drug Interactions

Simultaneous use of the drug biloba^® Forte with anticoagulants or acetylsalicylic acid is not recommended.

Conditions of supply of pharmacies

The drug is resolved to application as an agent Valium holidays.

Conditions and terms

The drug should be protected from moisture, inaccessible to children at temperature not exceeding 25 ° C. Shelf life – 2 year.